Similar articles

• HIV and hepatotropic viruses: interactions and treatments.

  McCarron B, Main J, Thomas HC. McCarron B, et al. Int J STD AIDS. 1997 Dec;8(12):739-45; quiz 745-6. doi: 10.1258/0956462971919192. Int J STD AIDS. 1997. PMID: 9433946 Review. No abstract available.
• Management of viral hepatitis: clinical and public health perspectives--a consensus statement. CASL Hepatitis Consensus Group. Canadian Association for Study of the Liver.

  Sherman M. Sherman M. Can J Gastroenterol. 1997 Jul-Aug;11(5):407-16. doi: 10.1155/1997/454278. Can J Gastroenterol. 1997. PMID: 9286474 Review. No abstract available.
• Chronic viral hepatitis.

  Garcia G, Gentry KR. Garcia G, et al. Med Clin North Am. 1989 Jul;73(4):971-83. doi: 10.1016/s0025-7125(16)30648-4. Med Clin North Am. 1989. PMID: 2471027 Review.
• Antiviral therapy of chronic viral hepatitis. ACG Committee on FDA-Related Matters.

  Di Bisceglie AM, Hoofnagle JH. Di Bisceglie AM, et al. Am J Gastroenterol. 1990 Jun;85(6):650-4. Am J Gastroenterol. 1990. PMID: 2112881 Review. No abstract available.
• Hygienists and patients should be alert to hepatitis.

  Miller CH. Miller CH. RDH. 1989 Jun;9(6):36, 39, 41. RDH. 1989. PMID: 2502818 No abstract available.